首页> 外文OA文献 >Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

【2h】

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

机译：致甲基化DNA序列作为癌症生物标志物的临床应用：NCI联合的标准，方法，测定，试剂和工具的EDRN和NIST研讨会

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jacob Kagan; Sudhir Srivastava; Peter E. Barker; Steven A. Belinsky; Paul Cairns;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for Integrating Biomarkers into Clinical Development of New Therapies for Lung Cancer Leading to the Inception of "Master Protocols" in Lung Cancer [J] . Shakun M. Malik, Richard Pazdur, Jeffrey S. Abrams, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2014,第10期

机译：NCI联合胸腔恶性肿瘤指导委员会的共识性报告：FDA关于将生物标志物整合到肺癌新疗法临床开发中的战略的研讨会，从而导致了肺癌“主要方案”的产生
2. Standards for Plasma and Serum Proteomics in Early Cancer Detection: A Needs Assessment Report from the National Institute of Standards and Technology-National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18–19, 2005 [J] . David M. Bunk, Gilbert S. Omenn, Paul D. Wagner, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2006,第9期

机译：早期癌症检测中血浆和血清蛋白质组学的标准：美国国家标准技术研究院的需求评估报告-美国国家癌症研究所标准，方法，测定，试剂和技术研讨会，2005年8月18日至19日
3. Novel methylated biomarkers and a robust assay to detect circulating tumor dna in metastatic breast cancer [J] . FacklerM.J., BujandaZ.L., UmbrichtC., Cancer research: The official organ of the American Association for Cancer Research, Inc . 2014,第8期

机译：新型甲基化生物标记物和用于检测转移性乳腺癌中循环肿瘤dna的强大测定方法
4. Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for Integrating Biomarkers into Clinical Development of New Therapies for Lung Cancer Leading to the Inception of Master Protocols in Lung Cancer [O] . Shakun M. Malik, Richard Pazdur, Jeffrey S. Abrams, -1

机译：NCI胸腔恶性肿瘤联合指导委员会的共识性报告：FDA关于将生物标志物整合到肺癌新疗法临床开发中的战略的研讨会从而导致了肺癌主要方案的产生
5. Standards for Plasma and Serum Proteomics in Early Cancer Detection: A Needs Assessment Report from the National Institute of Standards and Technology-National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18–19, 2005 [O] . Peter E Barker, Paul D Wagner, Stephen E Stein, 2006

机译：早期癌症检测中血浆和血清蛋白质组学标准：国家标准与技术研究所的需求评估报告 - 国家癌症研究所标准，方法，测定，试剂和技术研讨会，2005年8月18日至19日

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

著录项

引文网络

相似文献

相关主题

期刊订阅